8-K: KORU Medical Systems Announces Results of 2025 Annual Shareholder Meeting

KORU Medical Systems reports the outcomes of its 2025 Annual Meeting of Shareholders, including the election of directors, approval of executive compensation, and ratification of independent accountants.

Summary

• KORU Medical Systems held its 2025 Annual Meeting of Shareholders on May 14, 2025.
• Shareholders elected R. John Fletcher, Robert A. Cascella, Donna French, Joseph M. Manko, Jr., Shahriar (Shar) Matin, Linda Tharby, and Edward Wholihan to the Company's board of directors.
• The election results show that each nominee received over 23 million votes 'For'.
• Shareholders approved, on an advisory basis, the compensation of the Company's executive officers with 23,167,952 votes 'For'.
• The appointment of Cherry Bekaert LLP as the Company's independent registered public accountants for the 2025 fiscal year was ratified with 36,910,101 votes 'For'.

Sentiment

Score: 7

Explanation: The document reports standard corporate governance matters, indicating a neutral to slightly positive sentiment due to the successful completion of the annual meeting and approval of all proposals.

Positives

• All proposed resolutions, including the election of directors, the advisory vote on executive compensation, and the ratification of the independent auditor, were approved by shareholders.

Industry Context

This announcement is a routine disclosure following a company's annual shareholder meeting, ensuring transparency and compliance with securities regulations.

Stakeholder Impact

• Shareholders have exercised their voting rights on key company matters.
• The board of directors is confirmed, ensuring continuity of leadership.
• Executive compensation is approved, aligning management interests with shareholder value.

Key Dates

Keywords

Annual Meeting, Shareholders, Election of Directors, Executive Compensation, Auditor Ratification, KORU Medical Systems